NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.4 Other immunomodulating drugs > Osteosarcoma - mifamurtide - NICE TAG TA235

Osteosarcoma - mifamurtide - NICE TAG TA235

1.1 Mifamurtide in combination with postoperative multi-agent chemotherapy is recommended within its licensed indication as an option for the treatment of high-grade resectable non-metastatic osteosarcoma after macroscopically complete surgical resection in children, adolescents and young adults and when mifamurtide is made available at a reduced cost to the NHS under the patient access scheme.

http://www.nice.org.uk/guidance/TA235

Site by Devopa
© Copyright 2019 NHS. All rights reserved.